Cost Plus Drugs

Cost Plus Drugs is a healthcare venture initiated by Mark Cuban in 2022. The company aims to reduce medication costs by bypassing traditional intermediary wholesalers and working directly with drug manufacturers, thereby providing more transparent and affordable pricing for prescriptions.

CCI Score

49.05

-0.02% April 18

Latest Event

Cost Plus Drugs Empowers Independent Pharmacies

Mark Cuban announced that Cost Plus Drugs will work directly with drug manufacturers and partner with independent pharmacies to bypass Pharmacy Benefit Managers (PBMs). The initiative, aimed at reducing medication costs and preventing 'pharmacy deserts', supports a more transparent and ethical healthcare system while challenging monopolistic practices in the pharmaceutical supply chain.

Take Action

So what can you do? Support Cost Plus Drugs by shopping, spreading the word, or offering your support.

Shop Alternatives SEE ALL: Sally Beauty

Tilray

CVS
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

LEADER

Cost Plus Drugs is currently rated as a Leader.

+45 to +100 CCI Score

Companies in this range actively lead the fight against authoritarianism by rejecting oppressive practices and championing democratic values. They implement robust policies, engage in transparent governance, and drive initiatives that set the standard for corporate responsibility.

Latest Events

MAR

28

2025

Cost Plus Drugs Empowers Independent Pharmacies
77.50

Mark Cuban announced that Cost Plus Drugs will work directly with drug manufacturers and partner with independent pharmacies to bypass Pharmacy Benefit Managers (PBMs). The initiative, aimed at reducing medication costs and preventing 'pharmacy deserts', supports a more transparent and ethical healthcare system while challenging monopolistic practices in the pharmaceutical supply chain.
JUL

13

2024

Cost Plus Drugs Embraces Transparent Drug Pricing Model
48.37

At the Summer 2024 Total Pharmacy Solutions Summit on July 13, 2024, Cost Plus Drugs' VP of Pharmacy Relations and Chief Privacy Officer, Erin Albert, presented the company's disruptive transparent pricing strategy, featuring a 15% markup and the Team Cuban Card network. This approach is designed to empower independent pharmacies, provide clarity on medication costs, and challenge traditional, opaque pharmaceutical supply chains.
+70

Business Practices and Ethical Responsibility

March 28

Cost Plus Drugs demonstrates a strong commitment to ethical business practices by implementing a transparent drug pricing model. The clear 15% markup and open disclosure of costs support consumer empowerment, aligning with progressive values by challenging opaque, profit-focused strategies traditionally observed in the pharmaceutical industry.

How Mark Cuban Cost Plus Drug Company Is Approaching Drug Pricing Transparency
+30

Economic and Structural Influence

March 28

By establishing the Team Cuban Card network and facilitating a business model that supports independent pharmacies, Cost Plus Drugs is bolstering local economic structures and community healthcare. This initiative challenges the dominance of large intermediaries and supports resilient economic practices.

How Mark Cuban Cost Plus Drug Company Is Approaching Drug Pricing Transparency
JAN

15

2024

Domestic Production to Address Drug Shortages
24.49

In early 2024, Mark Cuban’s Cost Plus Drugs began producing essential generic medications such as epinephrine and norepinephrine at a Dallas manufacturing hub. This move is designed to alleviate chronic drug shortages and enhance pricing transparency by bypassing opaque intermediaries like pharmacy benefit managers.
+30

Business Practices and Ethical Responsibility

March 28

By launching domestic production and bypassing traditional middlemen, the company is promoting greater transparency in drug pricing and better addressing systemic issues in the pharmaceutical supply chain. This ethical business practice challenges entrenched industry norms that often contribute to unfair pricing and restricted access, aligning with progressive principles.

Mark Cuban Cost Plus Drugs: More impact on shortages than costs - STAT
+25

Economic and Structural Influence

March 28

The establishment of a domestic manufacturing facility in Dallas addresses structural and economic challenges within the U.S. drug supply chain. By reducing reliance on lower-standard international sources and potentially mitigating widespread shortages, the company contributes positively to correcting market failures and improving public health infrastructure.

Mark Cuban Cost Plus Drugs: More impact on shortages than costs - STAT
AUG

22

2023

Cost Plus Drugs Joins New Blue Shield PBM Consortium
34.83

On August 22, 2023, Blue Shield of CA announced its decision to move away from CVS by forming a multi-vendor consortium that includes Amazon Pharmacy for at-home drug delivery and Mark Cuban’s Cost Plus Drugs for benefit design and medication access. This shift is aimed at reducing costs and increasing price transparency in prescription drugs.
+50

Business Practices and Ethical Responsibility

March 28

Cost Plus Drugs' inclusion in the new PBM consortium underscores its commitment to ethical business practices by bypassing traditional intermediaries to offer transparent and affordable medication pricing. This initiative supports patient access and reflects progressive, socially responsible business models in healthcare.

CVS, Amazon Pharmacy, and Cost Plus Drugs: PBM Disruption or a Blip on the Radar?
+30

Economic and Structural Influence

March 28

The consortium's formation is set to disrupt the entrenched pharmacy benefit management market by challenging incumbent profit-driven intermediaries. This strategic move aims to re-balance economic power in the healthcare sector, leading to a more equitable system.

CVS, Amazon Pharmacy, and Cost Plus Drugs: PBM Disruption or a Blip on the Radar?
JAN

01

2023

Cost Plus Drugs Expands Social Mission Through Strategic Partnership
60.05

Cost Plus Drugs, a public benefit corporation headed by Mark Cuban, announced a new partnership with RxPreferred to incorporate its affordable, transparent drug pricing into employer-sponsored benefit plans. This move aims to enhance healthcare accessibility and dismantle traditional opaque pharmaceutical pricing practices.
+80

Business Practices and Ethical Responsibility

March 28

By transparently pricing medications and bypassing traditional wholesalers, Cost Plus Drugs is reinforcing ethical business practices. Its expansion into employer-sponsored plans through a partnership with RxPreferred further underscores a commitment to accessibility and fair competition in the healthcare sector, aligning with progressive values.

Mark Cuban's Cost Plus Drug Company Expands Social Mission - Work Comp Training, Online Courses, Research, News – WorkCompAcademy
+70

Economic and Structural Influence

March 28

The strategic collaboration with RxPreferred amplifies the company’s economic and structural influence by enabling a broader reach into employer-provided healthcare benefits. This integration not only improves access to affordable prescriptions but also challenges entrenched pharmaceutical pricing models, promoting a more equitable healthcare environment.

Mark Cuban's Cost Plus Drug Company Expands Social Mission - Work Comp Training, Online Courses, Research, News – WorkCompAcademy